My Authors
Read all threads
Features of #COVID19 @ACCinTouch #CCAACC
🔹fever predominant feature
🔹cough (less often productive)
🔹cough presents on discharge (Lancet paper)
🔹 more than pneumonia
🔹 abnormal coagulation: ⬆️ d-dimer so anticoag needed
@TheLancet @Drroxmehran @CMichaelGibson @hmkyale
Rapid deterioration seen quite often. Cases below demonstrate this: #COVID19
Discussion of this dilemma of ACEI and ARBs: question still remains. We don’t have evidence to stop these and shouldn’t yet.
🔹48% have HTN, less with HTN who survive (~20%)
🔹limited data to say stop anti-RAS
🔹 need studies
@ACCinTouch @hmkyale @DrJenniferCo_Vu
@hmkyale thanks the Chinese Teams for sharing the knowledge #WeAreAllInThisTogether and also for not just caring for patients but continuing the science and publishing this so we can better care for patients here ♥️ #oneworld #onefamily @ACCinTouch
Normal life is changing. It is a CoVID19 Life. It is a Pandemic life. Wear marks. Protect everyone. #COVID19
#COVID19 is a global issue:
♥️Threat to global health with it spreading across the world
♥️acute cardiac injury seen in at least 10%
Hypothesis of #cardiacInjury by #COVID19 ♥️
🔹ACE2 mediated damage
🔹hypoxia damage
🔹microvascular damage
Management of #COVID19 and #heartdysfunction
🔹questions persist about AntiRAS drugs but we don’t know
🔹antiplatelet drugs: continue but watch for bleeding
🔹statins: watch LFTs
🔹 watch for interaction of antiretrovirals and CVD drugs
Summary of Management of #COVID19 in those with #CVD
♥️ early management
♥️diagnosis in time
♥️therapy for those with severe cases
♥️ be aware of drug interaction
#COVID19 Pandemic but prior experience in China resulted in rapid response but 3.8% of Chinese healthcare workers infected
🔹 peak in healthcare worker deaths but steadily decreased
Treatment of #AMI during #COVID19 crisis shown from our Chinese colleagues:
♥️fever and respiratory inventory first
♥️ thrombocytopenia
♥️ remote consultation by cardiologists encouraged
♥️ instability: is it pneumonia or the AMI?
Safety of Cardiac patients:
♥️avoid unnecessary hospitalizations: there won’t be beds for all so stable disease stay home!!! For their safety
♥️remote consultations
♥️ reduce interaction
♥️ screen for fever: fever clinic, screen at entry of hospital
@athenapoppas @DickKovacs
As @hmkyale pointed out: this is not JUST a pulmonary disease. Cardiac patients at the highest risk.
Question: should we check troop one on all cases of #COVID19?
🔹 most will have elevated troponin
🔹 when critical it will be dramatically elevated
🔹 💔 injury common
@MinnowWalsh asks how you changed your approach to routine patients?
🔹 China closed routine clinics
🔹 used internet consultations
🔹 ER was open but encouraged patients not to be exposed in clinics
🔹 AMI treatment changed in #CoVID19: #thrombolytics not #PCI
Patients with underlying Cardiac disease are at the greatest risk based on data we have from China #covid19 @ACCinTouch
Important to be aware that drugs we use can damage the ♥️
🔹 risk of complete heart block
🔹 risk of cardiomyopathy
With antiretroviral therapy #COVID19 so be aware of this @ACCinTouch @hmkyale
Thanks @hmkyale for asking my question about #NSAIDS given the warnings about using this and whether it increases risk. Seems that the Chinese experience doesn’t answer this. We just don’t know it seems. (If I understood this correctly-someone correct me if I didn’t understand)
Missing some Tweet in this thread? You can try to force a refresh.

Enjoying this thread?

Keep Current with Dr. Martha Gulati

Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

Twitter may remove this content at anytime, convert it as a PDF, save and print for later use!

Try unrolling a thread yourself!

how to unroll video

1) Follow Thread Reader App on Twitter so you can easily mention us!

2) Go to a Twitter thread (series of Tweets by the same owner) and mention us with a keyword "unroll" @threadreaderapp unroll

You can practice here first or read more on our help page!

Follow Us on Twitter!

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just three indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!